DMTTF
Price:
$0.1117
Market Cap:
$52.43M
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2021-06-07
Stock Exchange
PNK
Ticker
DMTTF
According to Small Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.23. This represents a change of 3.42% compared to the average of -2.16 of the last 4 quarters.
The mean historical PE Ratio of Small Pharma Inc. over the last ten years is -6.41. The current -2.23 PE Ratio has changed 3.39% with respect to the historical average. Over the past ten years (40 quarters), DMTTF's PE Ratio was at its highest in in the February 2021 quarter at 0. The PE Ratio was at its lowest in in the May 2020 quarter at -98.22.
Average
-6.41
Median
-2.73
Minimum
-20.18
Maximum
0
Discovering the peaks and valleys of Small Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -20.18
Year | PE Ratio | Change |
---|---|---|
2023 | -1.30 | -68.76% |
2022 | -4.16 | -79.41% |
2021 | -20.18 | -Infinity% |
The current PE Ratio of Small Pharma Inc. (DMTTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.55
5-year avg
-6.41
10-year avg
-6.41
Small Pharma Inc.’s PE Ratio is greater than Cellectis S.A. (-2.93), greater than Biotron Limited (-4.24), less than Resverlogix Corp. (-1.28), greater than Covalon Technologies Ltd. (-111.00), less than Bioasis Technologies Inc. (0), greater than Mosaic ImmunoEngineering Inc. (-23.07), greater than Ceapro Inc. (-2.99),
Company | PE Ratio | Market cap |
---|---|---|
-2.93 | $183.12M | |
-4.24 | $11.30M | |
-1.28 | $11.23M | |
-111.00 | $72.60M | |
0 | $284.08K | |
-23.07 | $7.24M | |
-2.99 | $13.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Small Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Small Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Small Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for Small Pharma Inc. (DMTTF)?
What is the highest PE Ratio for Small Pharma Inc. (DMTTF)?
What is the 3-year average PE Ratio for Small Pharma Inc. (DMTTF)?
What is the 5-year average PE Ratio for Small Pharma Inc. (DMTTF)?
How does the current PE Ratio for Small Pharma Inc. (DMTTF) compare to its historical average?